AXIOS November 28, 2023
Amid widespread drug shortages, President Biden is outlining a plan to increase domestic production of essential pharmaceuticals — including by leveraging a defense law used to bolster countermeasures against COVID-19.
Why it matters: The number of drugs in shortage is higher than at any point in almost a decade, while U.S. drug manufacturers largely depend on overseas suppliers for active pharmaceutical ingredients.
- Health care and national security experts for years have called for moving more drug manufacturing to the U.S., partly to guard against disruptions from a future pandemic or military conflict.
Driving the news: Biden announced Monday that he’ll use the Defense Production Act, among other measures, to create more essential medicines in the U.S.
- The...
Today's Sponsors
Today's Sponsor